Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Special Everyday – that is our promise, and we base our service on it. With the values of team spirit, agility and customer focus that shape our work, we are making Manor the number 1 omnichannel